Today’s video is inspired by a question I received regarding questions study participants should ask if they’re considering joining a clinical trial. I decided it would make a great topic for discussion. Please let me know what you think regarding questions clinical trial participants should be asking before they decide to enroll in a study.
This video is my reaction to an absurd article I read which basically argues that clinical trials are compromised because they are conducted by physicians who are doing the trials for monetary reasons. I would argue that all businesses are conducted to generate profits, and clinical trials are not any different. I also remind the author of the fact that the entire drug industry is a business as well. I would love to hear your guys’ thoughts on this as well.
Today we were joined by Julie and Darshan who do a good job introducing themselves in this Spreecast. Both guests have been on the show before, and both share a great deal of information in regards to study participants being billed for study procedures in clinical trials. Apparently, this is quite a common issue, and the three of us get right into this topic and a whole lot more in this insightful discussion. I’d love to hear any of your experiences with this issue and what we can do about it.
So I was going to do a Hollywood Squares type interview with myself and 3 other clinical trial professionals from India, but due to my lack of knowledge regarding Indian Standard Time, I showed up an hour and a half too early! Still, I was lucky enough to have Shilpa Garg of SenseCR join me. Shilpa is CEO of her own company in the clinical trials space in India and we were able to discuss a few important issues regarding clinical trials and India such as ethics, taking advantage of the poor population, informed consent and more. Looking forward to Shilpa helping me set up a Spreecast with more researchers from India soon! Thanks.
In this video, I get into why research clinics, CRO’s and other such clinical trial companies don’t utilize social media more often. I explain easy ways that are IRB friendly that one can use to help promote their company in both a b2b and b2c manner. (b2b is business to business, while b2c is business to consumer).
I received an interesting question from a viewer the other day regarding the topic of randomization and whether it can ever be rigged in order to assign study drug or a perceived better treatment option to a study participant. I explain what the randomization process usually entails, and how safeguards are put into place to prevent these very types of things from happening.
TroyPatt
JuliePfe
RaiKuldi
toddlemo
XTheGent
AGMednet
ArticIes
CustmrTC
gogreene
HealthTe
